医学
优势比
阻塞性睡眠呼吸暂停
内科学
置信区间
囊性纤维化
睡眠呼吸暂停
逻辑回归
心脏病学
作者
Aarti Shakkottai,Stephany Kim,Ron B. Mitchell
摘要
Abstract Introduction Obstructive sleep apnea (OSA) is common in children with cystic fibrosis (CF). Highly effective modulator therapies (HEMT) have led to improved sinopulmonary disease, but whether this translates to a lower frequency of OSA is unknown. Methods We conducted a single center retrospective review of polysomnographic (PSG) data from 2012 to 2023 in patients aged 0–18 years with CF to assess frequency of OSA. Participants were classified based on HEMT status. Logistic regression was used to quantify the association between HEMT and OSA with p < .05 considered significant. Results Forty‐nine children underwent PSG during the study period. Ten percent were of non‐White race and 24% were of Hispanic ethnicity. Twenty‐one children (43%) were on HEMT. These children were older than those not on modulators (11.6 vs. 6.4 years; p = .0001) but no different with respect to gender, race, nutritional status, or lung function. Twenty‐eight (57%) children had OSA. Odds of having OSA were higher in the HEMT group (odds ratio [OR] = 4.3; 95% confidence interval [CI]: 1.2–14.9; p = .02). Tonsillar hypertrophy was associated with an increased odds of having OSA independent of modulator status (OR: 6.6; 95% CI: 1.2–37.9; p = .03). Conclusions OSA is frequently diagnosed in the post‐HEMT era in this large, racially diverse group of children with CF. Children on HEMT were older and more likely to have OSA as compared to those not on modulators but similar in nutritional status, lung function, and presence of upper airway pathology. Prospective studies are needed to further clarify the relationship between HEMT and OSA in children with CF.
科研通智能强力驱动
Strongly Powered by AbleSci AI